Author:
Cahill K,Stead LF,Lancaster T
Reference68 articles.
1. Varenicline, an a4ß2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation;Gonzales;JAMA,2006
2. Efficacy of varenicline, an a4ß2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation;Jorenby;JAMA,2006
3. Smoking cessation with varenicline, a selective a4b2 nicotinic receptor partial agonist;Nides;Archives of Internal Medicine,2006
4. Varenicline is efficacious and well tolerated in promoting smoking cessation: Results from a 7-week, randomized, placebo- and bupropion-controlled trial [POS1-047];Oncken,2005
5. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist varenicline, for smoking cessation;Oncken;Archives of Internal Medicine,2006
Cited by
164 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献